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Background: Aerobic training has been used as one of the common treatments for type 2 diabetes;
however, further research on the individualized exercise program with the optimal intensity is still
necessary. The purpose of this study was to investigate the effects of supervised exercise training at the
maximal fat oxidation (FATmax) intensity on body composition, glycemic control, lipid proﬁle, and
physical capacity in older people with type 2 diabetes.
Methods: Twenty-four women and 25 men with type 2 diabetes, aged 60e69 years. The exercise groups
trained at the individualized FATmax intensity for 1 h/day for 3 days/week over 16 weeks. No dietary
intervention was introduced during the experimental period. Whole body fat, abdominal fat, oral glucose
tolerance test, lipid proﬁle, and physical capacity were measured before and after the interventions.
Results: FATmax intensity was at 41.3± 3.2% VO2max for women and 46.1± 10.3% VO2max for men.
Exercise groups obtained signiﬁcant improvements in body composition, with a special decrease in
abdominal obesity; decreased resting blood glucose concentration and HbA1c; and increased VO2max,
walking ability, and lower body strength, compared to the non-exercising controls. Daily energy intake
and medication remained unchanged for all participants during the experimental period.
Conclusion: Beside the improvements in the laboratory variables, the individualized FATmax training can
also beneﬁt daily physical capacity of older people with type 2 diabetes.
© 2019 The Society of Chinese Scholars on Exercise Physiology and Fitness. Published by Elsevier
(Singapore) Pte Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Type 2 diabetes is a chronic disease which would lead to
blindness, kidney failure, heart attacks, stroke, and lower limb
amputation, if not treated properly.1 Currently main treatments of
type 2 diabetes include dietary management,2 physical exercise,3,4
medicine,5 and bariatric surgery,6 with the major purposes of
controlling blood glucose and decreasing body fat.7 Among these
treatments, we focused on aerobic exercise treatment for type 2
diabetes in the present study. American Diabetes Association rec-
ommends the patients to engage in walking or cycling at least
150min per week at moderate to vigorous intensity.3 Thering, and Sciences, University
tralia.
Exercise Physiology and Fitness. P
es/by-nc-nd/4.0/).
a) at University of Southern Queenslan
 No other uses without permission. Cocommonly used exercise intensities are at 50%e70% maximal ox-
ygen uptake (VO2max) or at a heart rate (HR) of 110e140 bpm.8
However, these intensity ranges are too broad to determine a
particular exercise intensity for individual patients. Therefore,
further research on themost appropriate exercise programwith the
optimal intensity, mode, duration, and frequency is still necessary.4
During aerobic exercise with a gradually increased exercise in-
tensity, fat oxidation rate will increase to the peak at a certain in-
tensity and then begins to decline; and from this intensity onwards,
carbohydrate oxidation takes precedent.9 The exercise intensity at
the peak fat oxidation has been deﬁned as the maximal fat oxida-
tion rate (FATmax).10 FATmax is a low-to-moderate exercise in-
tensity. Our team has reported that women with type 2 diabetes
(63± 2 yrs) reach their FATmax at 37% VO2max11; while another
study has shown that the FATmax intensity was at 34% VO2max in
women with type 2 diabetes (58± 7 yrs).12 The studies of FATmax
in older men with type 2 diabetes are scarce up to now. FATmaxublished by Elsevier (Singapore) Pte Ltd. This is an open access article under the CC
d from ClinicalKey.com.au by Elsevier on September 29, 2019.
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diabetes. Firstly, aerobic exercise at a low-to-moderate intensity
would be much easier to do and safer for older people.13 Secondly,
deduced from the deﬁnition of FATmax, theoretically exercise at
FATmax intensity would burn much more fat as energy, compared
with other aerobic intensities ranges. In the literature, there are few
studies of physical training at FATmax exercise intensity in people
with type 2 diabetes.11 In the present study, we employed a FATmax
training program to investigate its effects on body fat, glycemic
control, and physical capacity in daily life as a special focus in both
older women and men with type 2 diabetes. The hypothesis was
that FATmax training would improve the measured variables of the
participants, compared to those of the non-exercising control
group's responses.Methods
Participants
The participants were 25 women and 29 men with type 2 dia-
betes, aged 60e69 years. They were recruited via local medical
practitioners, following the diagnostic criteria: 1) a fasting plasma
glucose concentration of 7.0mmol/L or higher; or 2) a plasma
glucose concentration of 11.1mmol/L or higher two hours after a
75-g oral glucose tolerance test (OGTT).14 The history of their type 2
diabetes was 6e11 years. Exclusion criteria were heart disease,
uncontrolled hypertension, pulmonary diseases, impaired renal or
liver function, or inability to participate in exercise training due to
orthopedic or neurological limitations. All participants took oral
hypoglycemic drugs (metformin and/or sulfonylureas), but none of
them were being treated with insulin. Other medicines included
antihypertensive agents [ACE inhibitor, diuretic, or others. Fourteen
(56%) participants from the exercise groups and 15 (63%) from the
control groups] and lipid-lowering agents [statin, ﬁbrate, or others.
7 (28%) from the exercise groups and 10 (42%) from the control
groups]. Medicines and respective doses were not changed during
the 16-week intervention. All female participants were post-
menopausal. All participants were physically inactive (<60min/
week of exercise) prior to the intervention. Before the baseline
tests, the exact details of the study were explained to the partici-
pants and a written informed consent to the study was obtained
from each of them. All methods and procedures of the present
study were approved by the Ethics Committee of Tianjin University
of Sport, China.Study design
All participants underwent a 2-day baseline examination that
included medical history, body composition, FATmax, glycated
hemoglobin (HbA1c), OGTT, and lipid proﬁle in Day 1; while the
measurements of predicted VO2max and physical capacity in Day 2.
The participants were instructed to abstain from coffee and alcohol
for 48 h before the tests. Then, the participants were allocated to
the exercise group or control group. A third party who was not
involved in the present study arranged participants’ family names
in an alphabetical order. Odd numbered participants were allocated
to the exercise group and even numbered participants to the con-
trol group. Women and men were organised separately. Exercise
groups took part in supervised exercise training at the individual-
ized FATmax intensity. Control participants were required to
maintain their habitual physical activity. Body composition, blood
variables, predicted VO2max, and physical capacity were measured
again at the end of the experiments. No diet intervention was
introduced during the experimental period for all participants.Downloaded for Anonymous User (n/a) at University of Southern Quee
For personal use only. No other uses without permissioBody composition
Each participant's body mass and height was measured (Omron
ultrasonic weightMETER HNH-219, Dalian, China) to calculate body
mass index (BMI). Waist circumference was measured at the level
of the umbilicus horizontally without clothing. Hip circumference
was measured at the level of the greatest protrusion of the gluteal
muscles with underwear. Waist-hip ratio was calculated. After
overnight fast, body composition was measured using a dual-
energy X-ray absorptiometry (DXA) (Prodigy Advance, GE Health-
care Lunar, USA). Total body fat (%) was determined as a portion of
the total amount of fat in the entire body mass. Fat mass and fat-
free mass were also calculated. To assess abdominal obesity, the
abdominal subcutaneous and visceral fat areas at the umbilical
level were estimated by a bioelectrical impedance analysis equip-
ment (ORMRN, HDS-2000 DUALSCANR, OMRON Healthcare Co.,
Kyoto, Japan).
FATmax measurement
FATmaxof each participant in the exercise groups wasmeasured
at baseline. The participants refrained from any vigorous physical
activity 24 h and fasted for at least 10 h before the test, which was
carried out in the morning between 8:00e10:00 to avoid circadian
variance. A graded treadmill walking-running protocol, same for
women and men, was used to measure the FATmax.11 Brieﬂy, there
was a warm-up walking at 2.5 km/h with an incline of 1% for 3min.
Participants then stepped off the treadmill to do 3min of static
stretching and had a 2-minute sitting rest. The ﬁrst stage of exercise
was set at a speed of 3.5 km/h with an incline of 1% for 3min. The
speed was increased to 4.0 km/h for 3min as the second stage,
4.5 km/h for 3min as the third stage, and 5.0 km/h for 3min as the
fourth stage before the respiratory exchange ratio (RER) reached
1.0. Oxygen uptake (VO2) and carbon dioxide production (VCO2)
were measured by using an open-circuit indirect gas analyser
(Cortex Metalyzer 3B Gas Analyser, CORTEX Biophysik GmbH,
Germany), which was calibrated with the standard gas before each
test. Average gas values were recorded every 15 s during the exer-
cise test until the RER reached 1.0, at which point the test was
terminated. Fat oxidation rate was calculated following the stoi-
chiometric equation with the assumption that the urinary nitrogen
excretion rate was negligible:
Total fat oxidation¼ 1.67 x VO2 e 1.67 x VCO2
with VO2 and VCO2 in litres per minute. The value 1.67 was
derived from the volume of VO2 and VCO2 in oxidation of 1 gram of
fat.15 The exercise intensity at which the highest rate occurred was
deﬁned as the FATmax.10 HR was recorded continuously during the
test by an electrocardiogram. The corresponding HR at the FATmax
intensity (FATmax HR)16 was recorded and then applied individu-
ally to control the intensity of the following exercise training.
Estimated maximal oxygen uptake
VO2max was estimated by using a submaximal exercise test on a
bicycle ergometer and VO2 was measured using the same gas
analyser as in the FATmax test. The HR and the VO2 at the workload
of 25 and 75W were measured to develop the best-ﬁt line of HR
and VO2 for each participant. VO2max was then predicted from the
estimated maximal HR (220-age).17
Blood tests
A 6-ml fasting blood sample was collected to measure lipidnsland from ClinicalKey.com.au by Elsevier on September 29, 2019.
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cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C), and
high-density lipoprotein-cholesterol (HDL-C) were measured using
an Automatic Biochemical Analyser Hitachi 7800 (Hitachi High-
Technologies Corporation, Tokyo, Japan). HbA1c was measured by
an enzymatic method (Bio-Rad Laboratories, Hercules, CA, USA).
The OGTT was conducted after overnight fasting. The participant
drank 75 g of glucose dissolved in 200ml of water. The Roche Cobas
C501 Chemistry Analyser was used to measure plasma glucose
(hexokinase method) and insulin (radioimmunoassay) in the blood
samples taken at baseline and two hours later. The reagent kits for
glucose and insulin were purchased from the Roche Diagnostics
Shanghai Limited (Shanghai, China). Insulin resistance was esti-
mated by the homeostasis model assessment (HOMA-IR)¼ fasting
insulin (mU/mL) fasting plasma glucose (mmol/L)/22.5.18
Physical capacity tests
Six tests were performed, in a random order, to measure lower
body strength (30-s chair stand, the stand-up can be completed in
one minute), upper body strength (30-s arm curl, women 5 lb and
men 8 lb, the arm curl can be done in one minute), aerobic
endurance (6-min walk, the distance covered), lower body ﬂexi-
bility (chair sit-and-reach, measure the distance between the ﬁg-
ures to tip of toe), upper body ﬂexibility (back scratch, measure the
distance between the extended middle ﬁgures), and ability/dy-
namic balance (8-foot up-and go, record the time required to get up
from seated position, walk 8 foot, turn, and return to seated posi-
tion on the chair).19
Exercise training program
Exercise groups undertook 16 weeks of FATmax training, 1 h per
day for 3 times per week. The training session consisted of a 10-
minute warm-up period which involved skeletal muscle stretches
and joint movement. This was followed by walking or running with
the intensity controlled at the individualized FATmax HR. The ex-
ercise duration was increased gradually: 20e25min in week 1;
30e35min in weeks 2e5, and 45min in weeks 6e16. Short breaks
of 1e2min were allowed when it was necessary. Finally, there was
a 5-minute cool-down period comprised of slow walking. All
training sessions were supervised by the researchers and every
participant wore a HR monitor (Polar Electro, Finland) during the
training. An alarm on the HR monitor was set up at ±5 beats of the
FATmax HR to judge the moving speed. If the participant showed a
sign of hypoglycemia, such as hunger, trembling, heart racing, or
nausea, during training, exercise was stop immediately.
Dietary records
All participants were required to record a ﬁve-weekday dietary
diary at the beginning and the end of the experimental period. The
weight of the food and percentages of carbohydrate, fat, and pro-
tein in the food were estimated from the records. Daily energy
intake was then calculated by multiplying the proportion of car-
bohydrate, fat, and protein consumed with their respective energy
values (carbohydrate provides 4 kcal/g of energy, fat 9 kcal/g, and
protein 4 kcal/g). After removing the highest and lowest values, the
average of the other three days was reported as the daily energy
intake.11
Data analyses
All values were presented as Mean± SD. The independent
samples t-test was run at baseline to compare possible differencesDownloaded for Anonymous User (n/a) at University of Southern Queensl
For personal use only. No other uses without permission. Cin measured variables between the exercise and control groups.
Effects of FATmax training on themeasured variables were detected
using 2 times (before and after experiment) x 2 groups (exercise
and control) factorial design, split plot analysis of variance (SPA-
NOVA). The effect size (ES) of measured variables following inter-
vention was calculated.20 Within-group comparisons of
interventional period were evaluated using the paired-samples t-
test. Based on the data of body fat% change after the FATmax ex-
ercise training in diabetes patients from a previous study,11 the
sample size of the exercise group should be n ¼ 10 when
alpha ¼ 0.05 for a two-tailed test and power ¼ 0.80 (G*Power
3.1.9.4 statistical power analysis program). A p < 0.05 was regarded
as statistically signiﬁcant. All analyses were performed using the
SPSS Version 22 for Windows (SPSS Inc. USA).
Results
Twenty-ﬁve participants of the exercise groups (11 women and
14 man) completed the 16-week FATmax training program. Due to
time constraints, two participants from the exercise groups (one
woman and one man) and three from the control groups (three
men) discontinued the study. Therefore, the data of 25 participants
of the exercise groups and 24 of the control groups (13 women and
11 men) were reported. In the trained women, the FATmax was
0.30± 0.07 g/min (range 0.22e0.44 g/min), occurring at the VO2 of
12.21± 0.94ml/min/kg and at 41.34± 3.15% VO2max (range
34.55e44.98% VO2max). Estimated VO2max was 27.71± 4.14ml/
min/kg. The average FATmax HR was 96 ± 12 bpm. In the trained
men, the FATmax was 0.38± 0.12 g/min (range 0.27e0.60 g/min),
occurring at the VO2 of 13.99± 2.15ml/min/kg and at
46.05± 10.34% VO2max (range 31.16e67.20% VO2max). Estimated
VO2max was 29.04± 5.18ml/min/kg. The average FATmax HR was
95± 12 bpm.
There were no physical injuries or hypoglycemic events caused
by the exercise training. Dietary records did not show signiﬁcant
changes before and after the experimental period within and be-
tween the exercise and control groups. Combined together, the
average daily energy intake of female participants was
2145± 89 kcal/day at baseline and 2197± 94 kcal/day at the end of
the study (p> 0.05); the data for male participants were
2345± 105 kcal/day and 2318± 96 kcal/day, respectively (p> 0.05).
There was no difference in the variables of body composition
between the groups of both women and men at baseline. In female
participants, the exercise group signiﬁcantly decreased body mass,
BMI, body fat%, and fat mass; while the control group increased
body mass, BMI, abdominal subcutaneous fat area, and hip
circumstance (Table 1). In the men's groups, the exercise group
signiﬁcantly decreased body mass, BMI, body fat%, fat mass,
abdominal fat areas, waist circumference, and waist-to-hip ratio;
while the control group had a signiﬁcant increase in abdominal
visceral fat area following the intervention (Table 2).
There was no difference in the blood variables between the
groups of both women and men at baseline. For women, the ex-
ercise group signiﬁcantly decreased their HbA1c and fasting blood
glucose concentration and increased HDL-C concentration; while
the control group increased their LDL-C concentration after 16
weeks of interventions (Table 3). In the men's groups, the exercise
group obtained signiﬁcant decreases in HbA1c, resting and 2-hr
post-challenge blood glucose concentrations, and 2-hr post-
challenge blood insulin concentration; while increased their HDL-
c concentration. The decrease in insulin resistance of the exercise
group was very close to statistical signiﬁcance (p¼ 0.052). There
was no signiﬁcant change in the blood variables of the control
group (Table 4).
Both trained women and men signiﬁcantly increased theirand from ClinicalKey.com.au by Elsevier on September 29, 2019.
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Table 1
Age and body composition variables of the participants (Women).
Variables Exercise group (n¼ 11) Control group (n¼ 13) P for time x
group








Age (years) 63.9± 6.1 62.6± 3.8
Body height (cm) 156.2± 6.7 156.1± 6.7 0.053 0.01 157.5± 6.4 157.4± 6.3 0.104 0.02 0.591
Body mass (kg) 64.9± 7.7 62.8 ± 7.4* <0.05 0.28 65.9± 5.6 67.4 ± 5.8* <0.05 0.26 <0.01
BMI (kg/m2) 26.6± 2.2 25.8 ± 2.1* <0.05 0.37 26.7± 3.2 27.3 ± 3.0* <0.05 0.19 <0.01
Fat% 34.2± 8.3 31.4 ± 7.4* <0.05 0.36 35.9± 6.2 36.2± 6.8 0.687 0.05 <0.05
Fat mass (kg) 22.4± 7.6 19.9 ± 5.7* <0.05 0.42 23.7± 5.0 24.4± 5.5 0.230 0.13 <0.01
Fat-free mass (kg) 42.5± 5.4 42.9± 5.6 0.379 0.07 42.2± 5.1 43.0± 5.7 0.320 0.15 0.764
Abdominal subcutaneous fat
area (cm2)
209.9± 58.3 192.7± 53.7 0.057 0.31 212.5± 46.4 220.8 ± 49.1* <0.05 0.17 <0.01
Abdominal visceral fat area
(cm2)
85.6± 40.2 75.0± 27.6 0.081 0.30 88.2± 23.8 91.5± 21.0 0.321 0.15 <0.05
Waist circumstance (cm) 86.0± 13.0 81.9± 9.4 0.106 0.36 87.4± 8.9 91.9± 9.4 0.115 0.49 <0.05
Hip circumstance (cm) 99.9± 7.6 99.8± 8.4 0.979 0.01 97.8± 8.2 100.2 ± 8.2** <0.01 0.29 <0.05
Waist-hip ratio 0.86± 0.09 0.82± 0.07 0.194 0.50 0.89± 0.07 0.92± 0.07 0.340 0.31 0.120
Note: All data are presented in mean ± SD. BMI, body mass index. *p < 0.05; **p < 0.01.
Table 2
Age and body composition variables of the participants (Men).
Variables Exercise group (n¼ 14) Control group (n¼ 11) P for time x
group








Age (years) 63.9± 6.1 62.6± 3.8
Body height (cm) 169.1± 6.2 169.0± 6.2 0.336 0.02 170.8± 4.7 170.6± 5.0 0.113 0.04 0.296
Body mass (kg) 76.8± 7.9 73.5 ± 7.1*** <0.001 0.44 77.3± 7.1 78.5± 8.4 0.171 0.15 <0.001
BMI (kg/m2) 26.9± 2.1 25.7 ± 1.9*** <0.001 0.60 26.5± 2.1 27.0± 2.7 0.120 0.21 <0.001
Fat% 34.6± 4.6 31.2 ± 5.1** <0.01 0.70 34.5± 6.4 35.7± 6.4 0.184 0.19 <0.01
Fat mass (kg) 26.7± 5.0 23.0 ± 4.7* <0.001 0.76 26.8± 6.3 28.1± 6.0 0.099 0.21 <0.001
Fat-free mass (kg) 50.1± 5.0 50.5± 5.6 0.681 0.08 50.5± 5.4 50.4± 6.8 0.905 0.02 0.713
Abdominal subcutaneous fat
area (cm2)
214.4± 39.7 192.7 ± 40.6** <0.01 0.54 213.7± 69.4 220.5± 68.1 0.090 0.10 <0.01
Abdominal visceral fat area
(cm2)
106.2± 33.5 91.8± 29.6 <0.05 0.46 103.9± 44.8 112.4± 47.1 <0.01 0.18 <0.01
Waist circumstance (cm) 96.3± 7.8 91.4 ± 7.9*** <0.001 0.62 93.9± 11.8 93.6± 9.4 0.807 0.03 <0.01
Hip circumstance (cm) 100.4± 4.6 100.0± 5.7 0.654 0.08 99.0± 6.0 100.2± 7.7 0.620 0.17 0.492
Waist-hip ratio 0.96± 0.06 0.91 ± 0.06*** <0.001 0.83 0.95± 0.08 0.94± 0.08 0.610 0.13 0.155
Note: All data are presented in mean ± SD. BMI, body mass index. *p < 0.05; **p < 0.01; ***p < 0.001.
Table 3
Blood variables of the participants (Women).
Variables Exercise group (n¼ 11) Control group (n¼ 13)








P for time x
group
HbA1c (%) 6.90± 0.60 6.21 ± 0.64** <0.01 1.11 6.84± 0.77 6.92± 0.73 0.597 0.11 <0.01
Blood glucose (mmol/L)
Fasting 8.57± 1.53 7.98 ± 1.40* <0.05 0.48 8.57± 1.42 8.79± 1.25 0.316 0.16 <0.01
2-hr post-
challenge
12.75± 5.56 12.78± 6.45 0.979 0.01 11.90± 5.49 12.64± 5.31 0.296 0.14 0.520
Blood insulin (mU/ml)
Fasting 16.85± 9.64 16.15± 7.75 0.541 0.08 16.44± 6.17 16.89± 8.10 0.780 0.06 0.570
2-hr post-
challenge
45.10± 21.31 39.30± 19.55 0.351 0.28 46.94± 25.74 49.34± 28.99 0.552 0.09 0.210
Insulin resistance 6.60± 4.15 5.75± 2.82 0.168 0.24 6.33± 2.64 6.67± 3.43 0.665 0.11 0.241
TG (mmol/l) 3.54± 1.24 2.99± 1.62 0.098 0.38 3.56± 0.97 3.42± 1.13 0.596 0.13 0.295
TC (mmol/l) 5.27± 0.65 5.47± 0.93 0.274 0.25 5.24± 0.99 5.43± 1.01 0.542 0.19 0.959
HDL-C (mmol/l) 1.60± 0.34 1.93 ± 0.32** <0.01 1.00 1.56± 0.40 1.54± 0.29 0.802 0.06 <0.05
LDL-C (mmol/l) 3.27± 0.65 3.21± 0.81 0.748 0.08 3.30± 0.74 3.68 ± 0.60* <0.05 0.56 0.067
Note: All data are presented in mean ± SD. HbA1c, glycated hemoglobin. TG, triglyceride. TC, total cholesterol. HDL-C, high-density lipoprotein-cholesterol. LDL-C, low-density
lipoprotein-cholesterol. *p < 0.05; **p < 0.01.
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Table 4
Blood variables of the participants (Men).
Variables Exercise group (n¼ 14) Control group (n¼ 11) P for time x
group








HbA1c (%) 6.59± 0.57 6.21 ± 0.62** <0.01 0.64 6.58± 0.88 6.62± 0.84 0.731 0.05 <0.01
Blood glucose (mmol/L)
Fasting 8.60± 0.99 7.73 ± 1.18* <0.05 0.80 8.53± 1.20 8.96± 1.18 0.127 0.36 <0.01
2-hr post-
challenge
10.97± 3.46 8.66 ± 3.22* <0.05 0.69 10.76± 3.17 11.75± 3.77 0.174 0.28 <0.05
Blood insulin (mU/ml)
Fasting 12.60± 6.00 11.28± 6.50 0.418 0.21 12.26± 8.00 11.61± 7.28 0.475 0.08 0.736
2-hr post-
challenge
42.45± 30.63 30.99± 21.64 <0.05 0.43 41.08± 14.67 47.80± 16.79 0.062 0.43 <0.01
Insulin resistance 4.77± 2.12 3.82± 2.03 0.052 0.46 4.80± 3.35 4.70± 3.10 0.817 0.03 0.195
TG (mmol/l) 3.61± 1.16 3.13± 1.09 0.108 0.43 3.54± 1.31 3.42± 1.18 0.460 0.10 0.307
TC (mmol/l) 5.22± 1.03 5.23± 0.87 0.995 0.01 5.25± 0.86 5.37± 1.16 0.644 0.12 0.717
HDL-C (mmol/l) 1.46± 0.41 1.84 ± 0.46* <0.05 0.87 1.49± 0.38 1.52± 0.43 0.733 0.07 0.081
LDL-C (mmol/l) 3.19± 0.81 2.99± 0.73 0.174 0.26 3.17± 0.71 3.10± 0.46 0.789 0.12 0.652
Note: All data are presented in mean ± SD. HbA1c, glycated hemoglobin. TG, triglyceride. TC, total cholesterol. HDL-C, high-density lipoprotein-cholesterol. LDL-C, low-density
lipoprotein-cholesterol. *p < 0.05; **p < 0.01.
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16-week FATmax training; while no change in these variables of the
control groups. There was no change in the times of 30s arm curl,
chair sit-and-reach performance, the time used to complete the 8-
foot up-and go test for both trained women and men (Tables 5
and 6). In addition, the trained women improved their back
scratch result (p< 0.05); while the controlled women got a worse
result from their chair sit-and-reach test (p< 0.05) (Table 5).
Discussion
Main ﬁndings were that the 16-week FATmax training positively
changed body composition; improved glycemic control; and
increased VO2max and physical capacity in the trained women and
men. There were no favourable changes in these variables in the
control groups. Daily energy intakes and medication and dosages
remained unchanged for all participants during the experimental
period. Therefore, the overall outcome supports the hypothesis that
FATmax training is an effectively adjuvant therapy for managing
type 2 diabetes in older people.
The 16-week FATmax training achieved signiﬁcant changes in
body composition of both women and men; especially, the signif-
icant decrease in abdominal obesity. Known as the ‘sick fat’,21 the
fat depot around abdomen actively releases non-esteriﬁed fatty
acid, cytokines, and adipokines, which can cause systemic inﬂam-
mation and metabolic diseases.22,23 Related to the development of
type 2 diabetes, there is an association between abdominal fat and
insulin resistance in middle-aged people.24 Aerobic training at
other intensities, for example, 60e75% maximal HR trainingTable 5
Maximal oxygen uptake and ﬁtness capacity of the participants (Women).
Variables Exercise group (n¼ 11)




Maximal oxygen uptake (ml/
min/kg)
27.7± 4.1 31.1± 5.2 <0.05 0.7
30s arm curl with 5 Ib (times) 21± 3 24± 4 0.104 0.8
30s chair stand (times) 19± 5 23 ± 4*** <0.001 0.8
6-min walk (m) 512± 72 538 ± 63* <0.05 0.3
Chair sit-and-reach (cm) 3.9± 6.1 4.7± 4.5 0.443 0.1
Back scratch (cm) 13± 11 14 ± 10* <0.05 0.1
8-foot up-and-go (s) 5.8± 1.4 6.4± 1.0 0.111 0.4
Note: All data are presented in mean ± SD. *p < 0.05; ***p < 0.001.
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For personal use only. No other uses without permission. Copdecreased abdominal subcutaneous fat area25 and 60e65% of the
reserve HR training reduced visceral and subcutaneous adipose
tissue in type 2 diabetes patients.26 Referred to the FATmax training
studies specially, our team has found the decrease in abdominal fat
mass or area in overweight middle-aged women and older women
with type 2 diabetes following 10e12 weeks of FATmax
training.11,16 The present study provides further evidence that
FATmax is an effective exercise intensity to decrease abdominal
obesity, as well as whole body fat variables, for both older women
and older men with type 2 diabetes.
The OGTT results showed signiﬁcant decreases in resting blood
glucose for both trained women and men, as well as the 2-hr post-
challenge blood glucose for trained men only. The present study
consolidated the decrease in resting blood glucose of older women
with type 2 diabetes following FATmax training11; and expanded
the results to older menwith type 2 diabetes. The decrease in blood
glucose concentrations is in agreement with previous aerobic ex-
ercise studies in people with type 2 diabetes.27,28 HbA1c shows the
average blood glucose level over the previous two to three
months.29 Both trained women and men decreased their HbA1c
after the 16-week FATmax training. The results from trained
women supported a recent FATmax training study.11 Other aerobic
training studies have also reported decreased HbA1c in type 2
diabetes patients25,30; however, not all aerobic exercise studies
reported signiﬁcant change in this variable.31 Taken together, the
decreased blood glucose concentrations and HbA1c indicate that
FATmax is an effective exercise intensity to beneﬁt glycemic control
in older people with type 2 diabetes.
Another positive change in the blood tests was the increasedControl group (n¼ 13)




P for time x
group
2 28.0± 4.0 27.5± 4.1 0.683 0.13 <0.05
5 22± 5 23± 4 0.816 0.22 0.189
8 20± 3 19± 4 0.329 0.28 <0.001
8 495± 69 491± 76 0.658 0.06 <0.05
5 5.4± 6.7 7.9 ± 6.2* <0.05 0.39 0.283
0 16± 13 16± 14 0.637 0.01 0.061
9 6.0± 1.8 6.3± 1.5 0.413 0.18 0.611
d from ClinicalKey.com.au by Elsevier on September 29, 2019.
yright ©2019. Elsevier Inc. All rights reserved.
Table 6
Maximal oxygen uptake and ﬁtness capacity of the participants (Men).
Variables Exercise group (n¼ 14) Control group (n¼ 11) P for time x
group








Maximal oxygen uptake (ml/
min/kg)
29.0± 5.2 32.2± 6.7 <0.05 0.52 27.9± 3.3 27.2± 5.4 0.463 0.19 <0.05
30s arm curl with 8 Ib (times) 29± 6 31± 7 0.071 0.31 28± 6 27± 7 0.322 0.15 0.051
30s chair stand (times) 21± 6 25 ± 7** <0.01 0.88 22± 7 19± 7 0.089 0.65 <0.01
6-min walk (m) 537± 56 572 ± 52** <0.01 0.65 536± 68 543± 75 0.319 0.10 <0.05
Chair sit-and-reach (cm) 5.0± 7.6 4.7± 6.6 0.717 0.04 5.2± 10.0 5.9± 11.1 0.590 0.07 0.498
Back scratch (cm) 17± 10 18± 10 0.391 0.10 15± 14 14± 13 0.726 0.07 0.423
8-foot up-and-go (s) 5.4± 1.2 5.5± 1.5 0.590 0.07 5.7± 1.6 6.1± 1.8 0.358 0.23 0.495
Note: All data are presented in mean ± SD. **p < 0.01.
Y. Jiang et al. / Journal of Exercise Science & Fitness 18 (2020) 7e1312HDL-c concentration after the 16-week FATmax training in both
trained women and men. As a protective factor of cardiovascular
disease, HDL-c concentration has also been increased after aerobic
exercise training in older people with type 2 diabetes.28,32 The
present FATmax study supports these previous studies.
In the studies of exercise training for people with type 2 dia-
betes, the improvements in laboratory variables are important.
Furthermore, from the patients’ point of view, it would be more
important to evaluate the change in their daily physical activity
capacity. People with type 2 diabetes (59± 8 yrs) showed poorer
performance in 6-min walk, vertical jump, and upper body
strength, compared with those of the aged-matched healthy peo-
ple.33 To the best of our knowledge, the present study is the ﬁrst
trial of the effects of FATmax training on physical capacity in daily
life of older people with type 2 diabetes. We found that VO2max,
lower body strength andwalking ability of both trainedwomen and
men were increased after the FATmax training, but no signiﬁcant
change in upper body strength and body ﬂexibility. The main ex-
ercise mode employed in the present training program was
walking, so it is reasonable to explain the non-change in upper
body and ﬂexibility. That is the limitation of the current FATmax
training program. Future training program should add some upper
body muscle training and ﬂexibility training.
Conclusion
The 16-week FATmax exercise training program achieved im-
provements in body composition, blood glucose, lipid proﬁle, as
well as walking capacity and lower body strength in this group of
older people with type 2 diabetes, compared to non-exercising
controls. These results suggest, beside the improvements in the
laboratory variables, the individualized FATmax training can also
beneﬁt daily physical capacity of older people with type 2 diabetes.
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